Učitavanje...
Treatment of Chronic Active Antibody-mediated Rejection With Pulse Steroids, IVIG, With or Without Rituximab is Associated With Increased Risk of Pneumonia
BACKGROUND. The risk of infection associated with specific treatments of chronic active antibody-mediated rejection (cAMR) after kidney transplantation remains unknown. METHODS. This was a single-center study of kidney transplant recipients treated with pulse steroids, intravenous immunoglobulin (IV...
Spremljeno u:
| Izdano u: | Transplant Direct |
|---|---|
| Glavni autori: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Lippincott Williams & Wilkins
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7738046/ https://ncbi.nlm.nih.gov/pubmed/33335983 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000001080 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|